Form 4 Filing for Anixa Biosciences Inc.

This filing details a transaction by Amit Kumar, the Chief Executive Officer and a director of Anixa Biosciences Inc. On September 10, 2026, Mr. Kumar acquired 3,000 shares of the company's Common Stock at a price of $2.75 per share. This transaction was made under code "P", indicating a purchase. Following this acquisition, Mr. Kumar now owns 665,000 shares of Anixa Biosciences Inc. common stock directly. The filing also confirms that Mr. Kumar is not a ten percent owner and this transaction is not subject to Section 16 regulations. The report was signed on September 14, 2026.